Gene testing for diagnosing and treating heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enroll patients at the Cardiogenetic Center of the University of Ferrara, Italy, to collect detailed clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. The registry will document patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes to enhance understanding of the genetic basis of arrhythmias. By facilitating long-term follow-up, the study seeks to assess the natural history of these disorders and the effectiveness of various therapeutic interventions. Ultimately, it aims to identify risk factors associated with adverse outcomes, such as sudden cardiac death.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.
* Having a proven cardiogenetic disease

Exclusion Criteria:

* Refuse to provide informed consents
* Patients not having a cardiogenic disease

Where it's running

• Department of Cardiology, University Hospital of Ferrara
  Ferrara, Italy Recruiting

Study contacts

• Principal investigator: Cristina Balla, MD PhD — Università degli Studi di Ferrara
• Study coordinator: Cristina Balla, MD PhD
• Email: bllcst@unife.it
• Phone: +39 0532 239886

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using AI to enhance cardiology patient care

  This study is testing if using AI tools can help cardiologists make better decisions when treating patients with heart conditions compared to traditional methods.

  Recruiting Stanford University · Palo Alto, California · NCT06935253

• Predict Arrhythmia Risk with Intelligent Software

  Researchers are testing AI-powered predictions to see if clinicians can spot patients at risk for dangerous heart rhythms using bedside ECG data.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07792694

• Remote Balance in Everyday Life for young MI patients with distress

  This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.

  Recruiting Uppsala University · Uppsala · NCT07706816

• Well-being program for caregivers of patients with advanced heart or lung disease

  This study tests an 8-week, home-based wellness program delivered virtually to caregivers of people with advanced cardiac or pulmonary disease to see if it’s feasible and acceptable.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07685912

• Rhythm control for device-detected AHREs in adults with no prior AF

  This trial tests whether starting rhythm-control therapy plus risk-factor management helps people with device-detected AHREs lasting 6 minutes to 24 hours avoid progressing to clinical atrial fibrillation.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT07649109

• Seeing if short education videos help families understand pediatric heart conditions and speed up visits

  Short educational videos shown during pediatric cardiology visits are being tested to see if they help families understand their child's heart condition and make clinic visits run more smoothly.

  Recruiting Driscoll Children's Hospital · San Antonio, Texas · NCT07594041

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.